Association between Interleukin-21 Serum Level and IL-21 Genetic Polymorphism with the Cardiovascular Morbidity Risk in Rheumatoid Arthritis and Systemic Lupus Erythematosus Pati

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Interleukin 17 role as a biomarker in Systemic Lupus Erythematosus patients.

Polymorphisms of Interleukin-1β and Cytotoxic T lymphocyte Associated Antigen-4 Genes in Systemic Lupus Erythematosus

Clinical Association of Serum Interleukin-17 and Interleukin-6 in Systemic Lupus Erythematosus Patients

Assessment of Interleukin-34 Serum level In Children with Systemic lupus Erythematosus

Interleukin 26 in patients with systemic lupus erythematosus

Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rhe

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Serum Nerve Growth Factor, Interleukin-13 and Tumor Necrosis Factor - Αin patients with Systemic Lupus Erythematosus